Highlights Shimadzu Corporation

Equities

7701

JP3357200009

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-20 am EDT			5-day change	1st Jan Change
4,350 ^JPY	-0.21%		-0.09%	+10.35%

May. 10	Shimadzu Corporation announces an Equity Buyback for 12,500,000 shares, representing 4.24% for ¥25,000 million.	CI
May. 10	Shimadzu Corporation authorizes a Buyback Plan.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shimadzu Corporation announces an Equity Buyback for 12,500,000 shares, representing 4.24% for ¥25,000 million.	May. 10	CI
Shimadzu Corporation authorizes a Buyback Plan.	May. 09	CI
Final dividend	Mar. 27	FA
Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC.	Feb. 27	CI
Ex-dividend day for interim dividend	23-09-27	FA
AR advanced technology, Inc. has completed an IPO in the amount of Â¥924.21 million.	23-06-23	CI
Shyld AI and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology	23-06-22	CI
Shimadzu Corporation acquired Biomaneo.	23-06-08	CI
AR advanced technology, Inc. has filed an IPO.	23-05-19	CI
Shimadzu Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10	CI
Ex-dividend day for final dividend	23-03-29	FA
Shimadzu Corp. Shares Rise on Higher First-Half Profit	22-11-07	DJ
Ex-dividend day for interim dividend	22-09-28	FA
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion.	22-07-27	CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion.	22-05-30	CI
Shimadzu Shares Rise Sharply After Fiscal-Year Net Profit Rose 31%	22-05-10	DJ
Ex-dividend day for final dividend	22-03-29	FA
Rakuten Medical, Inc. and Shimadzu Corporation Enrolls First Patient in the U.S. Clinical Trial of Photoimmunotherapy	22-02-15	CI
Shimadzu Corporation Revises Earnings Guidance for the Year 2022	21-11-07	CI
Shimadzu Corporation Provides Interim and Full Year Dividend Guidance 2022	21-11-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shimadzu Corporation

Equities

7701

JP3357200009

Highlights

Filters